Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.480
-0.250 (-6.70%)
At close: Dec 5, 2025, 4:00 PM EST
3.540
+0.060 (1.72%)
After-hours: Dec 5, 2025, 7:59 PM EST
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 253 employees as of December 31, 2024. The number of employees decreased by 14 or -5.24% compared to the previous year.
Employees
253
Change (1Y)
-14
Growth (1Y)
-5.24%
Revenue / Employee
$1,339,870
Profits / Employee
$112,842
Market Cap
566.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IRWD News
- 9 days ago - Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025 - Seeking Alpha
- 26 days ago - Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance - Business Wire
- 6 weeks ago - Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta - Accesswire
- 4 months ago - Ironwood (IRWD) Q2 EPS Jumps 600% - The Motley Fool
- 4 months ago - Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance - Business Wire
- 7 months ago - Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire
- 7 months ago - Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire
- 8 months ago - Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - Business Wire